查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922657

日本介入性心臟病器材市场报告：按产品、最终用户和地区划分（2026-2034 年）

Japan Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本介入性心臟病器材市场规模达11.9亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到24.2亿美元，2026年至2034年的复合年增长率为8.22%。心臟病患病率上升、医疗技术的最新进展、扶持政策的出台以及微创手术（MI）相对于传统手术的日益普及，都是推动市场成长的关键因素。

介入性心臟病学器械是指用于经导管治疗结构性心臟疾病的各种专用仪器和设备。这些器械包括支架、导管、导管导引线、球囊和血管闭合装置。介入性心臟病学器材具有微创、精准、柔软性及先进技术整合等诸多特点。它们可用于多种手术，包括血管成形术、置入术、瓣环成形、先天性心臟疾病矫正术、经皮瓣膜修復术和冠状动脉血栓切除术。介入性心臟病学器械有助于改善患者预后、缩短恢復时间、降低感染风险、减少住院时间、减轻术中不适并提高诊断准确性。此外，它们还以其长期成本效益、低手术风险、高成功率以及能够满足不适合开胸手术的高风险患者的需求而闻名。

日本介入性心臟病器材市场趋势：

老年人中心臟病盛行率的上升，导致对包括介入治疗在内的先进心臟治疗的需求不断增长，从而推动了市场成长。此外，高血压、肥胖和糖尿病等文明病的增加，也增加了心血管疾病的风险，进一步促进了市场成长。医疗技术的进步催生了先进且有效的介入性心臟病器械，对市场成长产生了积极影响。此外，政府的支持性政策和对医疗基础设施的投资也推动了市场成长。由于经经皮冠状动脉介入治疗（PCI）恢復时间较短、风险较低，其相对于传统手术的日益普及也是市场成长的驱动因素。此外，医疗费用支出不断增长以及先进医疗程序的保险覆盖范围扩大，也是市场成长的重要驱动因素。能够进行介入性心臟病治疗的专家和医疗机构数量的增加，也对市场成长产生了正面影响。同时，全球和日本主要医疗设备公司之间在技术转移和产品开发方面日益增多的合作与伙伴关係，也推动了市场成长。此外，日本大众对心血管疾病及其治疗方法的认识不断提高，也是推动市场成长的因素之一。此外，旨在提高介入性心臟病器材疗效和安全性的持续研究和临床试验正在推动市场成长。同时，医疗基础设施的显着改善，包括能够支持介入性心臟病器材应用的先进医疗设施的建设，也在促进市场成长。此外，大量强有力的临床证据支持介入性心臟病器材的疗效和安全性，也为市场成长提供了动力。

本报告解答的关键问题

  • 日本介入性心臟病器材市场目前发展状况如何？您预计未来几年该市场将如何发展？
  • 新冠疫情对日本介入性心臟病器材市场产生了哪些影响？
  • 日本介入性心臟病器材市场按产品分類的市场组成是什么？
  • 日本介入性心臟病器材市场依最终用户分類的市场区隔如何？
  • 日本介入性心臟病器材市场价值链的不同阶段有哪些？
  • 日本介入性心臟病器材市场的主要驱动因素和挑战是什么？
  • 日本介入性心臟病器材市场的结构是怎么样的？主要企业有哪些？
  • 日本介入性心臟病器材市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 预测方法

第三章执行摘要

第四章 日本介入性心臟病器材市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本介入性心臟病器材市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

6. 日本介入性心臟病器材市场－依产品细分

  • 支架
  • 干涉导管
  • PTCA导管导引线
  • 球囊扩张设备
  • PTCA球囊扩张术

7. 日本介入性心臟病器材市场－依最终用户细分

  • 医院
  • 门诊手术中心
  • 其他的

第八章：日本介入性心臟病器材市场－按地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第九章 日本介入性心臟病器材市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十章主要企业概况

第十一章：日本介入性心臟病器材市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十二章附录

简介目录
Product Code: SR112026A19809

Japan interventional cardiology devices market size reached USD 1.19 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.42 Billion by 2034, exhibiting a growth rate (CAGR) of 8.22% during 2026-2034. The rising prevalence of cardiac ailments, recent advancements in medical technology, introduction of supportive policies, and the growing preference for minimally invasive (MI) procedures over traditional surgeries represent some of the key factors driving the market.

Access the full market insights report Request Sample

Interventional cardiology devices refer to a broad range of specialized tools and equipment utilized in the catheter-based treatment of structural heart diseases. They include stents, catheters, guidewires, balloons, and vascular closure devices, among others. Interventional cardiology devices possess various features, including minimally invasive (MI) nature, precision, flexibility, and advanced technological integration. They are employed in a variety of applications, including angioplasty, stent placement, valvuloplasty, congenital heart defect correction, percutaneous valve repair, and coronary thrombectomy. Interventional cardiology devices aid in improving patient outcomes, reducing recovery times, lowering the risk of infection, minimizing hospital stays, decreasing procedural discomfort, and enhancing diagnostic accuracy. In addition, they are known for their cost-effectiveness in the long term, lower surgical risks, high success rates, and ability to cater to high-risk patients who are not candidates for open-heart surgery.

JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET TRENDS:

The rising prevalence of cardiac ailments in the geriatric population, contributing to the heightened demand for advanced cardiac care, including interventional procedures, is propelling the market growth. Additionally, the increasing prevalence of lifestyle-related diseases, such as hypertension, obesity, and diabetes, which escalates the risk of cardiovascular diseases, is driving the market growth. Besides this, recent advancements in medical technology, leading to the development of more sophisticated and effective interventional cardiology devices, are positively influencing the market growth. Furthermore, the introduction of supportive policies and investments by the government in healthcare infrastructure is bolstering the market growth. In addition, the growing preference for MI procedures over traditional surgeries, owing to their reduced recovery times and lower risks, is catalyzing the market growth. Apart from this, the rising healthcare expenditure, coupled with enhanced insurance coverage for advanced medical procedures, is providing a considerable boost to the market growth. Moreover, the increasing number of specialized cardiologists and healthcare facilities that are equipped to perform interventional cardiology are positively affecting the market growth. Along with this, the growing collaboration and partnerships among leading global and local medical device companies for technology transfer and product development are stimulating the market growth. In addition, the rising awareness about cardiovascular diseases and their treatments among the Japanese population is driving the market growth. Furthermore, the ongoing research and clinical trials aiming to improve the efficacy and safety of interventional cardiology devices are strengthening the market growth. Besides this, the significant improvements in healthcare infrastructure, including the availability of advanced medical facilities that can support the adoption of interventional cardiology devices, are fueling the market growth. Additionally, the widespread availability of strong clinical evidence supporting the effectiveness and safety of interventional cardiology devices is favoring the market growth.

JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION:

Product Insights:

  • To get detailed segment analysis of this market Request Sample
  • Stents Drug Eluting Stents Bare Metal Stents Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Interventional Catheters IVUS Catheters Guiding Catheters Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • PTCA Guidewires
  • Balloon Inflation Device
  • PTCA Balloons Cutting Balloons Scoring Balloons Drug Eluting Balloons Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons
  • Stents Drug Eluting Stents Bare Metal Stents Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Drug Eluting Stents
  • Bare Metal Stents
  • Bio-Absorbable Stents
  • Interventional Catheters IVUS Catheters Guiding Catheters Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • IVUS Catheters
  • Guiding Catheters
  • Angiography Catheters
  • PTCA Guidewires
  • Balloon Inflation Device
  • PTCA Balloons Cutting Balloons Scoring Balloons Drug Eluting Balloons Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Drug Eluting Balloons
  • Normal Balloons

End User Insights:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan interventional cardiology devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan interventional cardiology devices market?
  • What is the breakup of the Japan interventional cardiology devices market on the basis of product?
  • What is the breakup of the Japan interventional cardiology devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan interventional cardiology devices market?
  • What are the key driving factors and challenges in the Japan interventional cardiology devices?
  • What is the structure of the Japan interventional cardiology devices market and who are the key players?
  • What is the degree of competition in the Japan interventional cardiology devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Interventional Cardiology Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Interventional Cardiology Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Interventional Cardiology Devices Market - Breakup by Product

  • 6.1 Stents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Drug Eluting Stents
      • 6.1.3.2 Bare Metal Stents
      • 6.1.3.3 Bio-Absorbable Stents
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Interventional Catheters
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 IVUS Catheters
      • 6.2.3.2 Guiding Catheters
      • 6.2.3.3 Angiography Catheters
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 PTCA Guidewires
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Balloon Inflation Device
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 PTCA Balloons
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Segmentation
      • 6.5.3.1 Cutting Balloons
      • 6.5.3.2 Scoring Balloons
      • 6.5.3.3 Drug Eluting Balloons
      • 6.5.3.4 Normal Balloons
    • 6.5.4 Market Forecast (2026-2034)

7 Japan Interventional Cardiology Devices Market - Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Ambulatory Surgical Centers
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Others
    • 7.3.1 Historical and Current Market Trends (2020-2025)
    • 7.3.2 Market Forecast (2026-2034)

8 Japan Interventional Cardiology Devices Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by End User
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by End User
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by End User
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by End User
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by End User
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by End User
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by End User
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by End User
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Interventional Cardiology Devices Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Interventional Cardiology Devices Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix